Inhaled loxapine (Adasuve®) for agitation associated with schizophrenia and bipolar disorder
Source: London New Drugs Group
Area: Evidence > Drug Specific Reviews
· Loxapine is a first-generation (typical) antipsychotic used for the symptomatic management of psychotic disorders.
· Loxapine inhalation is delivered via the breath-actuated Staccato® device, through which drug is quickly vaporised to form a small particle aerosol for systemic delivery after inhalation.
· In December 2012, the EU Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the granting of a marketing authorisation for inhaled loxapine (Adasuve®) for the rapid control of mild-to-moderate agitation in adult patients with schizophrenia or bipolar disorder.
· Loxapine inhalation is delivered via the breath-actuated Staccato® device, through which drug is quickly vaporised to form a small ...
Source: NeLM - Mental Health - Category: Psychiatry Source Type: news